Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Source
TFDA
(
ARTG
)
Rosuvastatin Intas should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,Prevention of Cardiovascular Events
Rosuvastatin Intas is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking, or a family history of premature coronary heart disease). Rosuvastatin Intas is indicated to:, Reduce the risk of nonfatal myocardial infarction
Reduce the risk of nonfatal stroke
Reduce the risk of coronary artery revascularisation procedures.,In patients with hypercholesterolaemia
Rosuvastatin Intas is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,Prior to initiating therapy with Rosuvastatin Intas, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.